Stifel Financial
BHVN

Stifel Financial’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Stifel Financial’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,071,644
Closed -$464M – 3449
2022
Q3 		$464M Sell
3,071,644
-195
-0% -$28.9K 0.76% 21
2022
Q2 		$448M Buy
3,071,839
+23,771
+0.8% +$3.04M 0.7% 20
2022
Q1 		$361M Sell
3,048,068
-1,927
-0.1% -$240K 0.49% 41
2021
Q4 		$420M Buy
3,049,995
+55,650
+2% +$7.08M 0.56% 36
2021
Q3 		$416M Buy
2,994,345
+424,304
+17% +$53M 0.61% 32
2021
Q2 		$249M Buy
2,570,041
+5,219
+0.2% +$424K 0.37% 66
2021
Q1 		$175M Buy
2,564,822
+22,348
+0.9% +$1.81M 0.29% 88
2020
Q4 		$218M Buy
2,542,474
+14,431
+0.6% +$1.22M 0.39% 64
2020
Q3 		$164M Buy
2,528,043
+36,957
+1% +$2.42M 0.34% 81
2020
Q2 		$182M Sell
2,491,086
-347,460
-12% -$18.5M 0.42% 63
2020
Q1 		$96.6M Buy
2,838,546
+1,500
+0.1% +$68.6K 0.27% 101
2019
Q4 		$154M Hold
2,837,046
– – 0.32% 82
2019
Q3 		$118M Sell
2,837,046
-1,492
-0.1% -$63K 0.3% 77
2019
Q2 		$124M Buy
2,838,538
+11,500
+0.4% +$648K 0.32% 73
2019
Q1 		$146M Buy
2,827,038
+107,500
+4% +$4.64M 0.41% 51
2018
Q4 		$101M Buy
2,719,538
+2,304,438
+555% +$83.1M 0.33% 73
2018
Q3 		$15.6M Hold
415,100
– – 0.04% 369
2018
Q2 		$16.4M Hold
415,100
– – 0.05% 369
2018
Q1 		$10.7M Sell
415,100
-200
-0% -$5.98K 0.03% 513
2017
Q4 		$11.2M Hold
415,300
– – 0.04% 485
2017
Q3 		$15.5M Buy
415,300
+100
+0% +$3.03K 0.05% 348
2017
Q2 		$10.4M Buy
+415,200
New +$9.56M 0.04% 458

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Stifel Financial's BHVN Position: Q4 2022 in Review

Stifel Financial sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 3,071,644 shares — an estimated $464M sold.

Stifel Financial first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $464M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Stifel Financial reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Stifel Financial sold 3,071,644 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $464M.
  • Stifel Financial first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • Stifel Financial's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $464M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Stifel Financial's 13F filing for Q4 2022, filed 13 Feb 2023.